Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat

Human and Experimental Toxicology

Volumn 25, Issue 4, 2006, Pages 187-194

  Shukla, Pradeep K ^a   Khanna, Vinay K ^a   Ali, M Mohd ^a   Maurya, Rakesh ^b   Khan, M Y ^c   Srimal, Rikhab C ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

Author keywords

Acorus calamus; Middle cerebral artery occlusion; Neuroprotection; Oxidative stress

Indexed keywords

AC 002; ACORUS CALAMUS EXTRACT; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ACORUS CALAMUS; AMINO ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; WEIGHT CHANGE;

ACORUS; ANIMALS; BODY WEIGHT; BRAIN ISCHEMIA; GLUTATHIONE; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY; MUSCULOSKELETAL EQUILIBRIUM; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; PLANT EXTRACTS; PLANT ROOTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

ACORUS CALAMUS; ANIMALIA;

EID: 33646239841     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327106ht613oa     Document Type: Article

References (41)

1. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001; 69: 369-81.
2. Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle artery occlusion in rat. Stroke 1997; 28: 2060-65.
3. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27: 1124-29.
4. Chabrier P, Auguet M, Spinnewyn B, Auvin S, Cornet S, Demerle-Pallardy C, Guilmard-Favre C, Marin J, Pignol B, Gillard-Roubert V, Roussillot-Charnet C, Schulz J, Viossat I, Bigg D, Moncada S. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci USA 1999; 96: 10824-29.
5. Tortella FC, Britton P, Williams A, May C, Newman AH. Neuroprotection (focal ischemia) and neurotoxicity (electro-encephalographic) studies in rats with AHN649, a 3-amino analogue of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist. J Pharmacol Exp Ther 1999; 291: 399-408.
6. Castillo J, Rama R, Davalos A. Nitric oxide-related brain damage in ischemic stroke. Stroke 2000; 31: 852-57.
7. Fisher M, Schaebitz W. An overview of stroke therapy. Past, present and future. Arch Intern Med 2000; 160: 3196-206.
8. Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001; 32: 570-76.
9. Raghu V, Dempsey RJ, Bowen KK. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat. Stroke 2004; 35: 179-84.
10. Kaste M. Thrombolysis in ischemic stroke: present and future. Role of combined therapy. Cerebrovasc Dis 2001; 11: 55-59.
11. Martinez-Vila E, Sieira PI. Current status and perspectives of neuroprotection in ischemic stroke treatment. Cerebrovasc Dis 2001; 11: 60-70.
12. Sinha K, Deogaonkar M, Jagannathan NR, Gupta YK. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rat. Eur J Pharmacol 2001; 428: 185-92.
13. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery model of stroke in rats. Life Sci 2002; 28: 655-65.
14. Gupta YK, Chaudhary G, Sinha K. Enhanced protection by melatonin and meloxicam combination in middle cerebral artery occlusion model of acute ischemic stroke in rat. Can J Physiol Pharmacol 2002; 80: 210-17.
15. Gupta YK, Sinha K, Chaudhary G, Jagannathan NR. Protective effect of adenosine against neuronal injury induced by middle cerebral artery occlusion in rats as evidenced by diffusion weighted imaging. Pharmacol Biochem Behav 2002; 72: 569-74.
16. Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol Sci 1999; 20: 191-98.
17. Chaudhary G, Sharma U, Jagannathan NR, Gupta YK. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 2003; 30: 399-404.
18. Vohora SB, Shah SA, Dandiya PC. Central nervous system studies on an ethanol extract of Acorus calamus rhizomes. J Ethnopharmacol 1990; 28: 53-62.
19. Martis G, Rao A, Karanth KS. Neuropharmacological activity of Acorus calamus. Fitoterapia 1991; 4: 331-37.
20. Shukla PK, Khanna VK, Ali MM, Maurya R, Handa SS, Srimal RC. Protective effect of Acorus calamus against acrylamide induced neurotoxicity. Phytother Res 2002; 16: 256-60.
21. Hazra R, Guha D. Acorus calamus: a traditional Indian herb and its role on ferric chloride induced experimental epileptic rat model. Ann Neurosci 2005; 13: 21 (Abstract O7).
22. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 1989; 20: 84-91.
23. 3H-dopa in various regions of the brain. J Neurochem 1966; 13: 655-59.
24. Bohme DH, Kosechzi R, Carsen S, Stern F, Marks N. Lipid peroxidation in human and rat brain tissue: developmental and regional studies. Brain Res 1977; 136: 11-21.
25. Hasan M, Haider SS. Acetyl-homocysteine thiolactone protects against some neurotoxic effects of thallium. Neurotoxicology 1989; 10: 257-62.
26. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 1984; 21: 130-32.
27. Lowry OH, Rosebrough NJ, Forr AL, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
28. Liu TH, Kato H, Araki T, Itoyama Y, Kato K, Kogure K. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat. Brain Res 1994; 644: 257-66.
29. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991; 71: 1185-95.
30. Hall ED. Antioxidant pharmacotherapy. In Ginsberg MD, Bogousslavsky J eds. Cerebrovascular disease: pathophysiology diagnosis and management. Blackwell, 1998: 710-20.
31. + ATPase activity during cerebral ischemia in mice. Neuroreport 1999; 10: 47-51.
32. Curtis-Prior P, Vere D, Fray P. Therapeutic value of Ginko biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 1999; 51: 535-41.
33. Wang Y, Chang CF, Chen HL, Deng X, Harvey BK, Cadet JL, Bickford PC. Dietary supplementation with blueberries, spinach or spirulina reduces ischemic brain damage. Exp Neurol 2005; 193: 75-84.
34. Hara H, Kato H, Kogure K. α-Tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res 1990; 510: 335-38.
35. Huh PW, Belayev L, Zhao W, Clemens JA, Panetta JA, Busto R, Ginsberg MD. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemia brain damage in rat brain. Eur J Pharmacol 2000; 389: 79-88.
36. Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott BJ. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 1999; 30: 2704-12.
37. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-76.
38. De Ryck M, Van Reempts J, Borgers M, Wauquier A, Janssen PJ. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rat. Stroke 1989; 20: 1383-90.
39. Markgraf CG, Green EJ, Watson B, McCabe PM, Schneiderman N, Dietrich WD, Ginsberg MD. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rat. Stroke 1994; 25: 153-59.
40. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion model in rat by intraluminal suture Neurological and pathological evaluation of an improved model. Stroke 1996; 27: 1616-22.
41. Zhao W, Belayev L, Ginsberg MD. Transient middle cerebral artery occlusion by intraluminal suture: II. Neurological deficits and pixel-based correlation of histopathology with local blood flow and glucose utilization. J Cereb Blood Flow Metab 1997; 17: 1281-90.